1 month ago
Antidepressant Fluvoxamine Shows Promise Against Long Covid Fatigue
A new study found that a common antidepressant called fluvoxamine can help people who are very tired for a long time after having Covid-19.
This condition is called Long Covid fatigue.
The study showed that people who took fluvoxamine felt less tired and could do more things in their daily lives.
Fluvoxamine is already used to treat depression and is not very expensive.
However, more research is needed to make sure it is safe and works well for everyone.
Over 65 million people around the world have Long Covid, and this medicine could be a good option for them.
Fluvoxamine, an antidepressant, significantly reduces fatigue in Long Covid patients.
The study involved 399 adults with persistent Long Covid fatigue over 60 days.
Fluvoxamine's effectiveness was 99% higher than the placebo.
Long Covid fatigue symptoms include extreme tiredness, brain fog, and poor concentration.
Over 65 million people worldwide experience Long Covid, and effective treatment options are needed.
- Who
- Adults with persistent Long Covid fatigue
- What
- A study found that fluvoxamine, an antidepressant, significantly reduces fatigue in Long Covid patients
- Where
- The study was published in the Annals of Internal Medicine
- When
- The study was conducted over 60 days
- Why
- To find effective treatment options for Long Covid fatigue
Fluvoxamine Supporters
Skeptics
Effectiveness
Fluvoxamine Supporters
Fluvoxamine significantly reduces fatigue and improves quality of life in Long Covid patients.
Skeptics
More research is needed to confirm the long-term safety and effectiveness of fluvoxamine.
Treatment Potential
Fluvoxamine Supporters
Fluvoxamine is widely available, inexpensive, and could be a promising treatment option.
Skeptics
Other medications like metformin did not show effectiveness, indicating the need for further exploration.
Key facts
- Study Participants
- 399 adults with persistent Long Covid fatigue
- Study Duration
- 60 days
- Effectiveness of Fluvoxamine
- 99% higher than placebo
- Common Symptoms of Long Covid Fatigue
- Extreme tiredness, brain fog, poor concentration, reduced exercise tolerance, sleep disturbances
- Global Long Covid Cases
- Over 65 million people
Quotes
Edward Mills
Senior author, professor in McMaster's Department of Health Research Methods, Evidence, and Impact, and co-principal investigator of the trial.
“This is an important step forward for patients who have been desperate for evidence-based options.”
NDTV
“Fluvoxamine showed consistent and meaningful benefits, and because it's already widely used and well understood, it has clear potential for clinical use.”
NDTV
Sources
Related news
ASUS Expands TUF Gaming Laptops in India With New Models
iPhone 18 Pro Max Leaks vs Secrets From Tata Cyberattack
OpenAI Rolls Out GPT-5.6-Cyber Cybersecurity Model After Astra AI Delay
Volvo ES90 And EX90 Electric Flagships Launch In India
ESFI announces Indian contingents for BRICS Esports Championship and GEG26
Alan Ritchson to Star in Netflix MotoGP Heist Thriller
Doctor With PCOS Took Inositol for 60 Days, Shares Results
Marksans Pharma Expands Allergy Treatment Portfolio with UK Approval
Marksans Pharma's UK Subsidiary Approved for Pain Relief Tablets
Experts: Onions Can Complement, But Not Replace Diabetes Medication
